Hill Research
AI-powered clinical research organization automating biostatistical workflows in drug development. Its TriClick™ platform transforms raw clinical trial data into regulatory-ready outputs in hours instead of weeks, while maintaining human oversight for compliance.
INDUSTRY
Clinical Research Technology, Artificial Intelligence
SECTOR
HealthTech / Clinical Research / AI
FOCUS
Trial Execution, Biostatistics Automation, TFL Generation
TECHNOLOGY
AI-Driven Automation, Agentic AI
STAGE OF INVESTMENT
Series A
HEADQUARTERS
Princeton, NJ
WEBSITE
Clinical trials generate enormous amounts of data, but turning that data into regulatory-ready outputs is still highly manual. Hill Research is building the infrastructure to make that process dramatically faster while keeping the human oversight a regulated industry requires
John Shufeldt, MD, JD, MBA, FACEP
Fund Manager
What they do.
Hill Research is an AI-powered clinical research company automating one of the most time-intensive parts of drug development. Its TriClick™ platform transforms raw clinical trial data into regulatory-ready tables, figures, and listings in hours instead of weeks, while maintaining human oversight for compliance and quality.
Why we invested.
Hill Research is building AI-native infrastructure for a part of clinical development that has remained heavily manual. TriClick™ has the potential to improve the speed, efficiency, and scalability of biostatistical workflows, and the platform is already generating revenue and working with a large pharmaceutical partner. That early commercial validation stood out to us in an industry where adoption can be difficult and regulatory requirements are high.
Leadership
Dr. Louise Ruihua Liu
Founder & CEO
Dr. Jack Li
CTO & Co-Founder
Dr. Rui Wu
Chief AI Officer
